Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 6
2022 2
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean covid sar study group[Corporate Author] (7 results)?
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion.
Planas D, Staropoli I, Michel V, Lemoine F, Donati F, Prot M, Porrot F, Guivel-Benhassine F, Jeyarajah B, Brisebarre A, Dehan O, Avon L, Boland WH, Hubert M, Buchrieser J, Vanhoucke T, Rosenbaum P, Veyer D, Péré H, Lina B, Trouillet-Assant S; COVID-SER study group; Hocqueloux L, Prazuck T, Simon-Loriere E, Schwartz O. Planas D, et al. bioRxiv [Preprint]. 2024 Feb 9:2023.11.20.567873. doi: 10.1101/2023.11.20.567873. bioRxiv. 2024. Update in: Nat Commun. 2024 Mar 13;15(1):2254. doi: 10.1038/s41467-024-46490-7 PMID: 38045308 Free PMC article. Updated. Preprint.
Assessment of serological techniques for screening patients for COVID-19 (COVID-SER): a prospective, multicentric study.
Trouillet-Assant S, Albert Vega C, Bal A, Nazare JA, Fascia P, Paul A, Massardier-Pilonchery A, D Aubarede C, Guibert N, Pitiot V, Lahousse M, Boibieux A, Makhloufi D, Simon C, Rabilloud M, Trabaud MA, Gueyffier F, Fassier JB; COVID-SER study group. Trouillet-Assant S, et al. BMJ Open. 2020 Nov 24;10(11):e041268. doi: 10.1136/bmjopen-2020-041268. BMJ Open. 2020. PMID: 33234651 Free PMC article.
Immunogenicity and efficacy of          heterologous ChAdOx1-BNT162b2 vaccination.
Pozzetto B, Legros V, Djebali S, Barateau V, Guibert N, Villard M, Peyrot L, Allatif O, Fassier JB, Massardier-Pilonchéry A, Brengel-Pesce K, Yaugel-Novoa M, Denolly S, Boson B, Bourlet T, Bal A, Valette M, Andrieu T, Lina B; Covid-Ser study group; Cosset FL, Paul S, Defrance T, Marvel J, Walzer T, Trouillet-Assant S. Pozzetto B, et al. Nature. 2021 Dec;600(7890):701-706. doi: 10.1038/s41586-021-04120-y. Epub 2021 Oct 21. Nature. 2021. PMID: 34673755
Anti-RBD IgG dynamics following infection or vaccination.
Harrache A, Saker K, Mokdad B, Generenaz L, Saade C, Pons S, Fassier JB; COVID-SER Study group; Bal A, Trabaud MA, Rabilloud M, Abichou-Klich A, Trouillet-Assant S. Harrache A, et al. Vaccine. 2024 Dec 2;42(26):126464. doi: 10.1016/j.vaccine.2024.126464. Epub 2024 Oct 20. Vaccine. 2024. PMID: 39432992 Free article.
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study.
Bal A, Brengel-Pesce K, Gaymard A, Quéromès G, Guibert N, Frobert E, Bouscambert M, Trabaud MA, Allantaz-Frager F, Oriol G, Cheynet V, d'Aubarede C, Massardier-Pilonchery A, Buisson M, Lupo J, Pozzetto B, Poignard P, Lina B, Fassier JB, Morfin F, Trouillet-Assant S; COVID-SER Study group. Bal A, et al. Sci Rep. 2021 Jul 22;11(1):14977. doi: 10.1038/s41598-021-93828-y. Sci Rep. 2021. PMID: 34294751 Free PMC article.
Publisher Correction: Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study.
Bal A, Brengel-Pesce K, Gaymard A, Quéromès G, Guibert N, Frobert E, Bouscambert M, Trabaud MA, Allantaz-Frager F, Oriol G, Cheynet V, d'Aubarede C, Massardier-Pilonchery A, Buisson M, Lupo J, Pozzetto B, Poignard P, Lina B, Fassier JB, Morfin F, Trouillet-Assant S; COVID-SER Study group. Bal A, et al. Sci Rep. 2021 Sep 23;11(1):19317. doi: 10.1038/s41598-021-99051-z. Sci Rep. 2021. PMID: 34556795 Free PMC article. No abstract available.
Combining SARS-CoV-2 interferon-gamma release assay with humoral response assessment to define immune memory profiles.
Mouton W, Oriol G, Compagnon C, Saade C, Saker K, Franc P, Mokdad B, Fleurie A, Lacoux X, Daniel S, Berthier F, Barnel C, Pozzetto B, Fassier JB, Dubois V, Djebali S, Dubois M, Walzer T, Marvel J, Brengel-Pesce K, Trouillet-Assant S; Covid ser study group. Mouton W, et al. Eur J Immunol. 2024 Jul;54(7):e2451035. doi: 10.1002/eji.202451035. Epub 2024 Apr 16. Eur J Immunol. 2024. PMID: 38627984
Type-I Interferon assessment in 45 minutes using the FilmArray® PCR platform in SARS-CoV-2 and other viral infections.
Mommert M, Perret M, Hockin M, Viel S, Belot A, Richard JC, Mezidi M, Fassier JB, Javouhey E; ANTOINE Study Group; COVID-SER Study Group; COVID-HCL Study Group; Hemmert A, Mallet F, Trouillet-Assant S, Brengel-Pesce K. Mommert M, et al. Eur J Immunol. 2021 Apr;51(4):989-994. doi: 10.1002/eji.202048978. Epub 2021 Jan 27. Eur J Immunol. 2021. PMID: 33314090 Free PMC article.
Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays.
Bal A, Trabaud MA, Fassier JB, Rabilloud M, Saker K, Langlois-Jacques C, Guibert N, Paul A, Alfaiate D, Massardier-Pilonchery A, Pitiot V, Morfin-Sherpa F, Lina B, Pozzetto B, Trouillet-Assant S; COVID SER Study Group. Bal A, et al. Clin Microbiol Infect. 2021 Jun;27(6):933-935. doi: 10.1016/j.cmi.2021.01.003. Epub 2021 Jan 13. Clin Microbiol Infect. 2021. PMID: 33450388 Free PMC article. No abstract available.
12 results